Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30 https://doi.org/10.3322/caac.21332.
Article
PubMed
Google Scholar
Department of Veterans Affairs Laryngeal Cancer Study Group, Wolf GT, Fisher SG, Hong WK, Hillman R, Spaulding M, Laramore GE, et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324(24):1685–1690. https://doi.org/10.1056/NEJM199106133242402.
Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349(22):2091–8 https://doi.org/10.1056/NEJMoa031317.
Article
CAS
PubMed
Google Scholar
Pignon JP, le Maître A, Maillard E, Bourhis J. MACH-NC collaborative group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009;92(1):4–14 https://doi.org/10.1016/j.radonc.2009.04.014.
Article
PubMed
Google Scholar
Wysolmerski JJ, Stewart AF. The physiology of parathyroid hormone-related protein: an emerging role as a developmental factor. Annu Rev Physiol. 1998;60:431–60 https://doi.org/10.1146/annurev.physiol.60.1.431.
Article
CAS
PubMed
Google Scholar
Burtis WJ. Parathyroid hormone-related protein: structure, function, and measurement. Clin Chem. 1992;38(11):2171–83.
Article
CAS
PubMed
Google Scholar
Luparello C, Burtis WJ, Raue F, Birch MA, Gallagher JA. Parathyroid hormone-related peptide and 8701-BC breast cancer cell growth and invasion in vitro: evidence for growth-inhibiting and invasion-promoting effects. Mol Cell Endocrinol. 1995;111(2):225–32 https://doi.org/10.1016/0303-7207(95)03577-t.
Article
CAS
PubMed
Google Scholar
Massfelder T, Dann P, Wu TL, Vasavada R, Helwig JJ, Stewart AF. Opposing mitogenic and anti-mitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: a critical role for nuclear targeting. Proc Natl Acad Sci U S A. 1997;94(25):13630–5 https://doi.org/10.1073/pnas.94.25.13630.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tovar Sepulveda VA, Falzon M. Parathyroid hormone-related protein enhances PC-3 prostate cancer cell growth via both autocrine/paracrine and intracrine pathways. Regul Pept. 2002;105(2):109–20 https://doi.org/10.1016/s0167-0115(02)00007-1.
Article
CAS
PubMed
Google Scholar
Hastings RH, Asirvatham A, Quintana R, Sandoval R, Dutta R, Burton DW, et al. Parathyroid hormone-related protein-(38-64) regulates lung cell proliferation after silica injury. Am J Physiol Lung Cell Mol Physiol 2002;283(1):L12–21.https://doi.org/10.1152/ajplung.00308.2001.
Watson PH, Pickard BW. Nuclear trafficking of the G-protein-coupled parathyroid hormone receptor. Crit Rev Eukaryot Gene Expr. 2008;18(2):151–61 https://doi.org/10.1615/critreveukargeneexpr.v18.i2.40.
Article
PubMed
Google Scholar
Nishihara M, Kanematsu T, Taguchi T, Razzaque MS. PTHrP and tumorigenesis: is there a role in prognosis? Ann N Y Acad Sci. 2007;1117:385–92 https://doi.org/10.1196/annals.1402.046.
Article
CAS
PubMed
Google Scholar
Park SI, Lee C, Sadler WD, Koh AJ, Jones J, Seo JW, et al. Parathyroid hormone-related protein drives a CD11b+Gr1+ cell-mediated positive feedback loop to support prostate cancer growth. Cancer Res. 2013;73(22):6574–83 https://doi.org/10.1158/0008-5472.CAN-12-4692.
Article
CAS
PubMed
Google Scholar
García M, Rodríguez-Hernández CJ, Mateo-Lozano S, Pérez-Jaume S, Gonçalves-Alves E, Lavarino C, et al. Parathyroid hormone-like hormone plays a dual role in neuroblastoma depending on PTH1R expression. Mol Oncol. 2019;13(9):1959–75 https://doi.org/10.1002/1878-0261.12542.
Article
PubMed
PubMed Central
CAS
Google Scholar
Lv Z, Wu X, Cao W, Shen Z, Wang L, Xie F, et al. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma. J Exp Clin Cancer Res. 2014;33(1):100 https://doi.org/10.1186/s13046-014-0100-y.
Article
PubMed
PubMed Central
Google Scholar
Maurizi M, Almadori G, Ferrandina G, Distefano M, Romanini ME, Cadoni G, et al. Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer. 1996;74(8):1253–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kalyankrishna S, Grandis JR. Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol. 2006;24(17):2666–72 https://doi.org/10.1200/JCO.2005.04.8306.
Article
CAS
PubMed
Google Scholar
Ang KK, Andratschke NH, Milas L. Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy. Int J Radiat Oncol Biol Phys. 2004;58(3):959–65 https://doi.org/10.1016/j.ijrobp.2003.07.010.
Article
CAS
PubMed
Google Scholar
Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol. 2010;11(1):21–8 https://doi.org/10.1016/S1470-2045(09)70311-0.
Article
CAS
PubMed
Google Scholar
Depenni R, Cossu Rocca M, Ferrari D, Azzarello G, Baldessari C, Alù M, et al. Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting. Eur J Cancer. 2019;115:4–12 https://doi.org/10.1016/j.ejca.2019.03.022.
Article
PubMed
Google Scholar
Nadler E, Joo S, Boyd M, Black-Shinn J, Chirovsky D. Treatment patterns and outcomes among patients with recurrent/metastatic squamous cell carcinoma of the head and neck. Future Oncol. 2019;15(7):739–51.
Article
CAS
PubMed
Google Scholar
Picon H, Guddati AK. Mechanisms of resistance in head and neck cancer. Am J Cancer Res. 2020;10(9):2742–51.
CAS
PubMed
PubMed Central
Google Scholar
Cramer SD, Peehl DM, Edgar MG, Wong ST, Deftos LJ, Feldman D. Parathyroid hormone--related protein (PTHrP) is an epidermal growth factor-regulated secretory product of human prostatic epithelial cells. Prostate. 1996;29(1):20–29. https://doi.org/10.1002/(SICI)1097-0045(199607)29:1<20::AID-PROS3>3.0.CO;2-M.
Cho YM, Lewis DA, Koltz PF, Richard V, Gocken TA, Rosol TJ, et al. Regulation of parathyroid hormone-related protein gene expression by epidermal growth factor-family ligands in primary human keratinocytes. J Endocrinol. 2004;181(1):179–90 https://doi.org/10.1677/joe.0.1810179.
Article
CAS
PubMed
Google Scholar
Gilmore JL, Scott JA, Bouizar Z, Robling A, Pitfield SE, Riese DJ 2nd, et al. Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells. Breast Cancer Res Treat. 2008;110(3):493–505 https://doi.org/10.1007/s10549-007-9748-8.
Article
CAS
PubMed
Google Scholar
Gilmore JL, Gonterman RM, Menon K, Lorch G, Riese DJ 2nd, Robling A, et al. Reconstitution of amphiregulin-epidermal growth factor receptor signaling in lung squamous cell carcinomas activates PTHrP gene expression and contributes to cancer-mediated diseases of the bone. Mol Cancer Res. 2009;7(10):1714–28 https://doi.org/10.1158/1541-7786.MCR-09-0131.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chang WM, Lin YF, Su CY, Peng HY, Chang YC, Hsiao JR, et al. Parathyroid hormone-like hormone is a poor prognosis marker of head and neck Cancer and promotes cell growth via RUNX2 regulation. Sci Rep. 2017;7:41131 https://doi.org/10.1038/srep41131.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yamada T, Tsuda M, Ohba Y, Kawaguchi H, Totsuka Y, Shindoh M. PTHrP promotes malignancy of human oral cancer cell downstream of the EGFR signaling. Biochem Biophys Res Commun. 2008;368(3):575–81 https://doi.org/10.1016/j.bbrc.2008.01.121.
Article
CAS
PubMed
Google Scholar
Schweitzer DH, Boxman IL, Löwik CW, van Krieken JH, Weissglas MG, Baatenburg de Jong RJ, et al. Parathyroid hormone related protein and interleukin-6 mRNA expression in larynx and renal cell carcinomas from normocalcaemic and hypercalcaemic patients. J Clin Pathol. 1995;48(10):896–900 https://doi.org/10.1136/jcp.48.10.896.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354(6):567–78 https://doi.org/10.1056/NEJMoa053422.
Article
CAS
PubMed
Google Scholar
El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck Tumours. Lyon: IARC; 2017.
Google Scholar
Monego G, Lauriola L, Ramella S, D'Angelillo RM, Lanza P, Granone P, et al. Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 expression in human lung adenocarcinoma. Chest. 2010;137(4):898–908 https://doi.org/10.1378/chest.09-1358.
Article
CAS
PubMed
Google Scholar
Almadori G, Lauriola L, Coli A, Bussu F, Gallus R, Scannone D, et al. Minichromosome maintenance protein 7 and geminin expression: prognostic value in laryngeal squamous cell carcinoma in patients treated with radiotherapy and cetuximab. Head Neck. 2017;39(4):684–93 https://doi.org/10.1002/hed.24670.
Article
PubMed
Google Scholar
Lawless, J. F. and Singhal, K. Efficient screening of nonnormal regression models. Biometrics. 1978;34:318–327. https://doi.org/10.2307/2530022
Harrell FE. Regression modeling strategies. With applications to linear models, logistic and ordinal regression, and survival analysis. 2nd edition, Springer Series in Statistics, Springer International Publishing, Springer Nature Switzerland AG, 2015. ISBN 978–3–319-19424-0. https://doi.org/10.1007/978-3-319-19425-7.
Kooperberg C, Stone CJ, Truong YK. Hazard regression. J Am Stat Assoc. 1995;90:78–94 https://doi.org/10.1080/01621459.1995.10476491.
Article
Google Scholar
Edwards CM, Johnson RW. From good to bad: the opposing effects of PTHrP on tumor growth, dormancy, and metastasis throughout Cancer progression. Front Oncol. 2021;22(11):644303 https://doi.org/10.3389/fonc.2021.644303.
Article
Google Scholar
Kumari R, Robertson JF, Watson SA. Nuclear targeting of a midregion PTHrP fragment is necessary for stimulating growth in breast cancer cells. Int J Cancer. 2006;119(1):49–59 https://doi.org/10.1002/ijc.21802.
Article
CAS
PubMed
Google Scholar
Park SI, McCauley LK. Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells. Endocr Relat Cancer. 2012;19(3):243–54 https://doi.org/10.1530/ERC-11-0278.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bhatia V, Saini MK, Falzon M. Nuclear PTHrP targeting regulates PTHrP secretion and enhances LoVo cell growth and survival. Regul Pept. 2009;158(1–3):149–55 https://doi.org/10.1016/j.regpep.2009.07.008.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shen X, Qian L, Falzon M. PTH-related protein enhances MCF-7 breast cancer cell adhesion, migration, and invasion via an intracrine pathway. Exp Cell Res. 2004;294(2):420–33 https://doi.org/10.1016/j.yexcr.2003.11.028.
Article
CAS
PubMed
Google Scholar
Luparello C. Parathyroid hormone-related protein (PTHrP): a key regulator of life/death decisions by tumor cells with potential clinical applications. Cancers (Basel). 2011;3(1):396–407 https://doi.org/10.3390/cancers3010396.
Article
CAS
Google Scholar
Asadi F, Farraj M, Sharifi R, Malakouti S, Antar S, Kukreja S. Enhanced expression of parathyroid hormone-related protein in prostate cancer as compared with benign prostatic hyperplasia. Hum Pathol. 1996;27(12):1319–23 https://doi.org/10.1016/s0046-8177(96)90344-5.
Article
CAS
PubMed
Google Scholar
Alipov GK, Ito M, Nakashima M, Ikeda Y, Nakayama T, Ohtsuru A, et al. Expression of parathyroid hormone-related peptide (PTHrP) in gastric tumours. J Pathol. 1997;182(2):174–9. https://doi.org/10.1002/(SICI)1096-9896(199706)182:2<174::AID-PATH840>3.0.CO;2-4.
Taguchi T, Kanematsu T. Clinicopathological implications of parathyroid hormone-related protein in human colorectal tumours. J Pathol. 1999;187(2):217–22. https://doi.org/10.1002/(SICI)1096-9896(199901)187:2<217::AID-PATH210>3.0.CO;2-0.
Atillasoy EJ, Burtis WJ, Milstone LM. Immunohistochemical localization of parathyroid hormone-related protein (PTHRP) in normal human skin. J Invest Dermatol. 1991;96(2):277–80 https://doi.org/10.1111/1523-1747.ep12464480.
Article
CAS
PubMed
Google Scholar
Kaiser SM, Sebag M, Rhim JS, Kremer R, Goltzman D. Antisense-mediated inhibition of parathyroid hormone-related peptide production in a keratinocyte cell line impedes differentiation. Mol Endocrinol. 1994;8(2):139–47 https://doi.org/10.1210/mend.8.2.8170470.
CAS
PubMed
Google Scholar
Huang Q, Yu GP, McCormick SA, Mo J, Datta B, Mahimkar M, et al. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer. 2002;34(2):224–33 https://doi.org/10.1002/gcc.10062.
Article
CAS
PubMed
Google Scholar
Orloff JJ, Reddy D, de Papp AE, Yang KH, Soifer NE, Stewart AF. Parathyroid hormone-related protein as a prohormone: posttranslational processing and receptor interactions. Endocr Rev. 1994;15(1):40–60 https://doi.org/10.1210/edrv-15-1-40.
CAS
PubMed
Google Scholar
Hastings RH, Montgrain PR, Quintana RA, Chobrutskiy B, Davani A, Miyanohara A, et al. Lung carcinoma progression and survival versus amino- and carboxyl-parathyroid hormone-related protein expression. J Cancer Res Clin Oncol. 2017;143(8):1395–407 https://doi.org/10.1007/s00432-017-2396-4.
Article
CAS
PubMed
Google Scholar
Ho PW, Goradia A, Russell MR, Chalk AM, Milley KM, Baker EK, et al. Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo. Oncogene. 2015;34(22):2922–33 https://doi.org/10.1038/onc.2014.217.
Article
CAS
PubMed
Google Scholar
Rabinowits G, Haddad RI. Overcoming resistance to EGFR inhibitor in head and neck cancer: a review of the literature. Oral Oncol. 2012;48(11):1085–9 https://doi.org/10.1016/j.oraloncology.2012.06.016.
Article
CAS
PubMed
Google Scholar
Boeckx C, Baay M, Wouters A, Specenier P, Vermorken JB, Peeters M, et al. Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistance. Oncologist. 2013;18(7):850–64 https://doi.org/10.1634/theoncologist.2013-0013.
Article
CAS
PubMed
PubMed Central
Google Scholar
Licitra L, Störkel S, Kerr KM, Van Cutsem E, Pirker R, Hirsch FR, et al. Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: analysis of data from the EXTREME and CRYSTAL studies. Eur J Cancer. 2013;49(6):1161–8 https://doi.org/10.1016/j.ejca.2012.11.018.
Article
CAS
PubMed
Google Scholar
Jung K, Kang H, Mehra R. Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC). Cancers Head Neck. 2018;3:3 https://doi.org/10.1186/s41199-018-0030-z.
Article
PubMed
PubMed Central
Google Scholar
Saki M, Toulany M, Rodemann HP. Acquired resistance to cetuximab is associated with the overexpression of Ras family members and the loss of radiosensitization in head and neck cancer cells. Radiother Oncol. 2013;108(3):473–8 https://doi.org/10.1016/j.radonc.2013.06.023.
Article
CAS
PubMed
Google Scholar
Shen X, Mula RV, Evers BM, Falzon M. Increased cell survival, migration, invasion, and Akt expression in PTHrP-overexpressing LoVo colon cancer cell lines. Regul Pept. 2007;141(1–3):61–72 https://doi.org/10.1016/j.regpep.2006.12.017.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bhatia V, Mula RV, Weigel NL, Falzon M. Parathyroid hormone-related protein regulates cell survival pathways via integrin alpha6beta4-mediated activation of phosphatidylinositol 3-kinase/Akt signaling. Mol Cancer Res. 2009;7(7):1119–31 https://doi.org/10.1158/1541-7786.MCR-08-0568.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sato K, Yamakawa Y, Shizume K, Satoh T, Nohtomi K, Demura H, et al. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors. J Bone Miner Res. 1993;8(7):849–60 https://doi.org/10.1002/jbmr.5650080711.
Article
CAS
PubMed
Google Scholar
Talon I, Lindner V, Sourbier C, Schordan E, Rothhut S, Barthelmebs M, et al. Antitumor effect of parathyroid hormone-related protein neutralizing antibody in human renal cell carcinoma in vitro and in vivo. Carcinogenesis. 2006;27(1):73–83 https://doi.org/10.1093/carcin/bgi203.
Article
CAS
PubMed
Google Scholar
Gessi M, Monego G, Calviello G, Lanza P, Giangaspero F, Silvestrini A, et al. Human parathyroid hormone-related protein and human parathyroid hormone receptor type 1 are expressed in human medulloblastomas and regulate cell proliferation and apoptosis in medulloblastoma-derived cell lines. Acta Neuropathol. 2007;114(2):135–45 https://doi.org/10.1007/s00401-007-0212-y.
Article
CAS
PubMed
Google Scholar